On the other hand, CCR6+ILC3s (Lti cells) have an anti-tumoral role in chemotherapy treated lung cancer by secreting CXCL10, which is a chemoattractant of CD4+ and CD8+ T cells. This evidence concerns the gene CD8A and lung carcinoma.